CureVac’s Collaboration with MD Anderson

Baker McKenzie advised CureVac N.V. on the deal. CureVac N.V., a global biopharmaceutical company developing transformative medicines based on messenger ribonucleic acid (mRNA), entered into a...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Nobia’s Rights Offering

Baker McKenzie legal advisor to the banks. Nobia AB (publ) has carried out a fully guaranteed preferential rights issue of shares of approximately SEK 1,262 million...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here